PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
2017 · Clinical Cancer Research · 943 citations
https://doi.org/10.1158/1078-0432.ccr-16-3215
H
Heng‐Huan Lee
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
125
Papers
7.9K
Citations
32
h-index
52
i10-index
Heng‐Huan Lee is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & CAR-T cell therapy research & PARP inhibition in cancer therapy. The author has an h-index of 32, co-authored 107 publications.
ORCID: 0000-0002-7813-1292Papers by this author
worksThe Translocon Sec61β Localized in the Inner Nuclear Membrane Transports Membrane-embedded EGF Receptor to the Nucleus
2010 · Journal of Biological Chemistry · 130 citations
https://doi.org/10.1074/jbc.m110.158659
Membrane-bound Trafficking Regulates Nuclear Transport of Integral Epidermal Growth Factor Receptor (EGFR) and ErbB-2
2012 · Journal of Biological Chemistry · 89 citations
https://doi.org/10.1074/jbc.m111.314799
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
2022 · Molecular Cancer · 69 citations
https://doi.org/10.1186/s12943-022-01655-0
Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex
2022 · Nature Cancer · 37 citations
https://doi.org/10.1038/s43018-022-00438-2
Treatment of Advanced Basal Cell Carcinoma with Sonidegib: Perspective from the 30-Month Update of the BOLT Trial
2017 · Future Oncology · 32 citations
https://doi.org/10.2217/fon-2017-0457
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat